Evidence map›Paper›PMID 31011838›Full record

ReviewCurrent cardiology reports2019

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.

Thwe Htay, Kyaw Soe, Arianna Lopez-Perez, Amy HoangAnh Doan, Michael A Romagosa, KoKo Aung

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. ADMET & DMPK · 2026
    Review
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Thwe HtayPaul L. Foster School of Medicine, Texas Tech University Health Sciences Center at El Paso, 5001 El Paso Drive, MSC 21009, El Paso, TX, 79905, USA. thwe.htay@ttuhsc.edu.
Kyaw SoeUniversity of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA.
Arianna Lopez-PerezPaul L. Foster School of Medicine, Texas Tech University Health Sciences Center at El Paso, 5001 El Paso Drive, MSC 21009, El Paso, TX, 79905, USA.
Amy HoangAnh DoanPaul L. Foster School of Medicine, Texas Tech University Health Sciences Center at El Paso, 5001 El Paso Drive, MSC 21009, El Paso, TX, 79905, USA.
Michael A RomagosaPaul L. Foster School of Medicine, Texas Tech University Health Sciences Center at El Paso, 5001 El Paso Drive, MSC 21009, El Paso, TX, 79905, USA.
KoKo AungPaul L. Foster School of Medicine, Texas Tech University Health Sciences Center at El Paso, 5001 El Paso Drive, MSC 21009, El Paso, TX, 79905, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThe aims of this review are to summarize recent data on mortality and cardiovascular disease (CVD) in type 1 and type 2 diabetes and to determine the interventions that could have contributed to a reduction in mortality. RECENT

findingsRecent studies found a downward trend in mortality and CVD among both diabetics and non-diabetics worldwide over the last few decades. The decline among diabetics is steeper than that among non-diabetics. Despite a parallel trend of decline, an approximately twofold difference in mortality and CVD between the two populations remains. A greater emphasis on glycemic control, management of cardiovascular risk factors, quality improvement programs, and advances in treatment of conditions associated diabetes are the factors that potentially contributed to the improvement. Although the trend is encouraging, a rising prevalence of diabetes will continue the absolute disease burden to the society. Future interventions should focus on prevention of diabetes.

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2HumansRisk FactorsCardiovascular diseaseCardiovascular mortalityCardiovascular riskDiabetes mellitus, type 1Diabetes mellitus, type 2MortalityTrend

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.